QIAGEN Hamburg GmbH v. Bio-Rad Laboratories, Inc.
1:22-cv-00458
Overview
Parties
Defendant
Bio-Rad Laboratories, Inc. Operating Company
Represented By
4 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Plaintiff
QIAGEN LLC Operating Company
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
QIAGEN Hamburg GmbH NPE (Individual / Inventor)
Represented By
2 Attorneys ListedPhillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No Co-Pending Disputes Detected in Current Index
There are no other active filings for this patent family across our indexed PTAB, U.S. Court, UPC, or EPO databases.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE41780
Chemical amplification based on fluid partitioning in an immiscible liquid
|
Filed: 2008-05-09
Issued: 2010-09-28
|
Expired (Term Ended)
Expires: 2024-08-17
|
|
|
US10782226
Cell capture system and method of use
|
Filed: 2020-07-15
Issued: 2020-09-22
|
Active (13.7 yrs remaining)
Expires: 2040-07-15
|
|
|
US10921237
Cell capture system and method of use
|
Filed: 2020-08-28
Issued: 2021-02-16
|
Active (13.8 yrs remaining)
Expires: 2040-08-28
|
|
|
US11073468
Cell capture system and method of use
|
Filed: 2020-08-27
Issued: 2021-07-27
|
Active (13.8 yrs remaining)
Expires: 2040-08-27
|
|
|
US11231355
Cell capture system and method of use
|
Filed: 2021-04-27
Issued: 2022-01-25
|
Active (14.4 yrs remaining)
Expires: 2041-04-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.
Procedural Motions & Interlocutory Orders
Total Motions
19
Dispositive
0
Granted
0
Denied
0
Pending / Review
9
Motions by Category
Key Dispositive Motions & Rulings